- Academic Editors
-
-
-
†These authors contributed equally.
Background: Postoperative atrial fibrillation (AF) has a complex
etiology, and beta-blockers are commonly recommended for its pharmacological
prevention. This study aims to assess the impact of beta-blocker therapy on
postoperative AF occurrence in patients undergoing aortic valve replacement,
mitral valve replacement, surgical revascularization of the myocardium, or a
combination of these procedures. Methods: The study
encompassed 472 patients who received aortic valve replacement, mitral valve
replacement, surgical revascularization, or their combination. We evaluated the
efficacy of preoperative and one-month postoperative beta-blocker administration
in preventing postoperative AF, and the associated risk factors involved in the
development of postoperative AF. Results: Of the total patient
population, 36% experienced postoperative AF. Our study demonstrated a
significant reduction in postoperative AF incidence among patients receiving
beta-blocker treatment (all p-values